Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Smart Money Cheers As Bank Of The Ozarks Inc (OZRK) Posts Big Revenue, Earnings Increases

Page 1 of 2

Bank Of The Ozarks Inc (NASDAQ:OZRK) reported net income of $44.8 million for the second quarter of fiscal year 2015 after trading closed today, a mighty 69.1% increase over the same quarter a year ago. Diluted earnings per common share for the quarter which ended June 30 was reported to be $0.51, jumping 50.0% from the second quarter of 2014. Wall Street was expecting an identical EPS of $0.51. Shares of the firm are up over 1% in after-hours trading following a 1.25% gain during Monday’s trading session. Bank Of The Ozarks said in its report that as of June 30, deposits stood at $7.09 billion, up by 42.2% from a year ago. Total assets on said date were $8.71 billion, up by 38.3% from a year ago. George Gleason, chairman and chief executive officer, boasted of the firm’s $456 million of growth in non-purchased loans and leases in the company’s press release announcing the results, as well as the $596 million growth in the unfunded balance of closed loans, its efficiency ratio of 36.6%, its net interest margin of 5.37%, and its excellent asset quality.

Bank Of The Ozarks Inc (OZRK), NASDAQ:OZRK, Yahoo Finance,

It’s important to note that the smart money was becoming bullish on Bank Of The Ozarks Inc (NASDAQ:OZRK) heading into the second quarter, likely based on many of the improving fundamental aspects of the company’s operationsd detailed in its latest earnings release. By the end of March, a total of 13 of the hedge funds tracked by Insider Monkey were long in this stock, up by one from the end of December. The total value of their holdings also increased by 31.20% quarter-over-quarter to $80.28 million by the end of March. This is a very bullish sign, as the stock declined by 2.61% during the first quarter. Hedge funds have also been right, as the stock gained 23.88% in the second quarter and is now up slightly in the third/

At Insider Monkey, we track hedge funds’ moves in order to identify actionable patterns and profit from them. Our research has shown that hedge funds’ large-cap stock picks historically delivered a monthly alpha of six basis points, though these stocks underperformed the S&P 500 Total Return Index by an average of seven basis points per month between 1999 and 2012. On the other hand, the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Index by an average of 95 basis points per month (read the details here). Since the official launch of our small-cap strategy in August 2012, it has performed just as predicted, returning over 135% and beating the market by more than 80 percentage points. We believe the data is clear: investors will be better off by focusing on small-cap stocks utilizing hedge fund expertise rather than large-cap stocks.

We also track insider transactions in the form of share purchases or sales to gauge the level of confidence company executives have in their firms. For Bank Of The Ozarks, there were no purchases in the first half of the year. There were, however, some insider sales. Director Catherine Freedberg sold 8,185 shares on June 5, while Director Ross Whipple sold 122,696 shares in three transactions in May.

With this in mind, let’s check out how hedge funds traded Bank Of The Ozarks Inc in the first quarter on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!